GIMERACIL\OTERACIL\TEGAFUR: 2,447 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,447
Total FAERS Reports
465 (19.0%)
Deaths Reported
906
Hospitalizations
2,447
As Primary/Secondary Suspect
201
Life-Threatening
31
Disabilities
First Report: 20021008 · Latest Report: 20250917
What Are the Most Common GIMERACIL\OTERACIL\TEGAFUR Side Effects?
#1 Most Reported
Myelosuppression
270 reports (11.0%)
#2 Most Reported
Diarrhoea
267 reports (10.9%)
#3 Most Reported
Decreased appetite
254 reports (10.4%)
All GIMERACIL\OTERACIL\TEGAFUR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 270 | 11.0% | 8 | 131 |
| Diarrhoea | 267 | 10.9% | 42 | 97 |
| Decreased appetite | 254 | 10.4% | 40 | 90 |
| Nausea | 214 | 8.8% | 16 | 49 |
| Disease progression | 199 | 8.1% | 45 | 26 |
| Neutropenia | 173 | 7.1% | 20 | 23 |
| Anaemia | 149 | 6.1% | 20 | 27 |
| Thrombocytopenia | 129 | 5.3% | 13 | 17 |
| Neuropathy peripheral | 128 | 5.2% | 15 | 13 |
| Drug ineffective | 127 | 5.2% | 36 | 33 |
| Vomiting | 125 | 5.1% | 16 | 35 |
| Malignant neoplasm progression | 119 | 4.9% | 53 | 41 |
| Fatigue | 111 | 4.5% | 10 | 18 |
| Febrile neutropenia | 110 | 4.5% | 32 | 42 |
| Off label use | 109 | 4.5% | 15 | 40 |
| Leukopenia | 107 | 4.4% | 6 | 8 |
| Interstitial lung disease | 94 | 3.8% | 38 | 47 |
| Death | 89 | 3.6% | 89 | 11 |
| White blood cell count decreased | 87 | 3.6% | 9 | 36 |
| Pyrexia | 86 | 3.5% | 18 | 57 |
Who Reports GIMERACIL\OTERACIL\TEGAFUR Side Effects? Age & Gender Data
Gender: 29.4% female, 70.6% male. Average age: 65.5 years. Most reports from: JP. View detailed demographics →
Is GIMERACIL\OTERACIL\TEGAFUR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 1 | 0 |
| 2003 | 1 | 1 | 0 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 0 |
| 2006 | 2 | 1 | 1 |
| 2007 | 1 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 4 | 2 | 1 |
| 2010 | 4 | 2 | 3 |
| 2011 | 10 | 3 | 1 |
| 2012 | 9 | 5 | 3 |
| 2013 | 21 | 7 | 6 |
| 2014 | 34 | 10 | 18 |
| 2015 | 36 | 13 | 17 |
| 2016 | 66 | 23 | 34 |
| 2017 | 67 | 18 | 46 |
| 2018 | 54 | 9 | 38 |
| 2019 | 65 | 12 | 30 |
| 2020 | 68 | 15 | 38 |
| 2021 | 83 | 12 | 45 |
| 2022 | 137 | 15 | 96 |
| 2023 | 82 | 13 | 49 |
| 2024 | 172 | 14 | 103 |
| 2025 | 53 | 11 | 31 |
What Is GIMERACIL\OTERACIL\TEGAFUR Used For?
| Indication | Reports |
|---|---|
| Gastric cancer | 725 |
| Pancreatic carcinoma | 145 |
| Gastric cancer stage iv | 107 |
| Adenocarcinoma gastric | 91 |
| Colon cancer | 91 |
| Colorectal cancer metastatic | 80 |
| Non-small cell lung cancer | 73 |
| Her2 positive gastric cancer | 70 |
| Metastases to liver | 69 |
| Rectal cancer | 59 |
GIMERACIL\OTERACIL\TEGAFUR vs Alternatives: Which Is Safer?
GIMERACIL\OTERACIL\TEGAFUR vs GINKGO
GIMERACIL\OTERACIL\TEGAFUR vs GIVINOSTAT
GIMERACIL\OTERACIL\TEGAFUR vs GIVOSIRAN
GIMERACIL\OTERACIL\TEGAFUR vs GLASDEGIB
GIMERACIL\OTERACIL\TEGAFUR vs GLATIRAMER
GIMERACIL\OTERACIL\TEGAFUR vs GLECAPREVIR\PIBRENTASVIR
GIMERACIL\OTERACIL\TEGAFUR vs GLEEVEC
GIMERACIL\OTERACIL\TEGAFUR vs GLICLAZIDE
GIMERACIL\OTERACIL\TEGAFUR vs GLIMEPIRIDE
GIMERACIL\OTERACIL\TEGAFUR vs GLIMEPIRIDE\ROSIGLITAZONE
Official FDA Label for GIMERACIL\OTERACIL\TEGAFUR
Official prescribing information from the FDA-approved drug label.